Valuation : Novartis AG

Market Cap 304B 262B 246B 225B 420B 28,771B 421B 2,918B 1,128B 14,734B 1,142B 1,117B 46,930B P/E 2026 *
22.7x
P/E 2027 * 19.2x
Enterprise Value 337B 290B 273B 249B 465B 31,877B 467B 3,233B 1,250B 16,324B 1,266B 1,238B 51,997B EV / Sales 2026 *
5.84x
EV / Sales 2027 * 5.41x
Free-Float
91.66%
Yield 2026 *
2.73%
Yield 2027 * 2.85%
1 day-2.82%
1 week+1.78%
Current month+1.78%
1 month-0.41%
3 months+6.92%
6 months+0.13%
Current year+14.47%
1 week 124.6
Extreme 124.6
132.68
1 month 121.02
Extreme 121.02
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 96.03
Extreme 96.03
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-3.18%+1.78%+22.62%+41.55% 304B
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.95%+0.23%+30.91%+37.78% 352B
+0.30%+0.67%+0.60%+11.25% 252B
-1.55%+1.11%+54.15%+75.59% 236B
+0.02%+2.24%-13.83%-55.80% 206B
-0.15%+3.65%+31.24%+103.39% 187B
-1.25%+1.75%+14.35%-17.22% 162B
Average -1.00%+1.31%+27.30%+45.21% 384.05B
Weighted average by Cap. -1.05%+0.67%+36.68%+63.35%

Financials

2026 *2027 *
Net sales 57.68B 49.6B 46.65B 42.59B 79.65B 5,455B 79.91B 553B 214B 2,794B 217B 212B 8,898B 61.38B 52.79B 49.65B 45.32B 84.76B 5,805B 85.04B 589B 228B 2,973B 231B 225B 9,469B
Net income 13.96B 12B 11.29B 10.31B 19.28B 1,320B 19.34B 134B 51.75B 676B 52.42B 51.28B 2,153B 15.53B 13.36B 12.56B 11.47B 21.45B 1,469B 21.52B 149B 57.58B 752B 58.33B 57.05B 2,396B
Net Debt 32.84B 28.25B 26.57B 24.25B 45.36B 3,106B 45.5B 315B 122B 1,591B 123B 121B 5,067B 27.9B 24B 22.57B 20.6B 38.53B 2,639B 38.66B 268B 103B 1,351B 105B 102B 4,304B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
07/09/26 CHF 125.46 -3.18% 3,116,102
04/09/26 CHF 129.58 -1.33% 2,616,060
03/09/26 CHF 131.32 0.00% 3,248,432
02/09/26 CHF 131.32 +0.27% 3,637,896
01/09/26 CHF 130.96 +6.25% 4,912,644
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
160.05USD
Average target price
155.20USD
Spread / Average Target
-3.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!